Skip Navigation

COVID-19 Update

We are vaccinating patients ages 16+. Learn more:

Vaccines | Testing | Patient Care | Visitor Guidelines | Coronavirus | Self-Checker |  Email Alerts

Michael Gilbert Goggins, M.B.B.Ch., M.D.

Headshot of Michael Gilbert Goggins
  • Professor of Pathology


Abdominal Pain, Bloating, Burping Belching, Cancer, Celiac Disease, Chest Pain, Clinical Gastroenterology, Colon Polyps, Constipation, Diarrhea, Digestive Disorders, Diverticulitis, Diverticulosis, Eosinophilic Esophagitis, Family History of Cancer, Gallbladder Diseases, Gallstones, Gas, Gastroenterology, Heartburn, Hiccups, Hoarseness, Indigestion, Irritable Bowel Syndrome, Malabsorption, Nausea, Pancreatic Cancer, Pancreatic Diseases, Peptic Ulcer, Rectal Bleeding, Rectal Problem, Reflux and Burning, Reflux Esophagitis, Stomach Pain, Stomach Ulcer, Swallowing Disorders, Vomiting, Weight Loss more

Research Interests

Early detection of pancreatic cancer; markers of pancreatic cancer; pancreatic cancer screening; familial pancreatic cancer; pancreatic cancer epigenetics; pancreatic cancer genetics more

Request an Appointment

Insurance Information

Maryland Phone


Outside of Maryland

Request Appointment

International Patients

Request Appointment


The Johns Hopkins Hospital (Main Entrance)

Appointment Phone: 410-933-7495
1800 Orleans St.
Sheikh Zayed Tower
Baltimore, MD 21287 map

Johns Hopkins Community Physicians - Green Spring Station

2360 W. Joppa Road
Joppa Concourse
Lutherville, MD 21093 map
Phone: 410-933-7495

Johns Hopkins Medicine - Green Spring Station

10755 Falls Road
Pavilion I
Lutherville, MD 21093 map
Phone: 410-933-7495


Dr. Michael G. Goggins is a professor of pathology, medicine and oncology at the Johns Hopkins University School of Medicine. He serves as director of the Pancreatic Cancer Early Detection Laboratory and is an attending physician in medicine in the Division of Gastroenterology and Hepatology at The Johns Hopkins Hospital, as well as a molecular biologist.

Dr. Goggins’ research interests include the role of germline BRCA2 mutations in pancreas cancer and characterizing the molecular genetic progression model for pancreas cancer.

He obtained his medical degree in 1988 from Trinity College of the University of Dublin, Ireland. He completed a residency in internal medicine and a fellowship in Gastroenterology at St. James' Hospital in Dublin. He obtained his Membership of the Royal College of Physicians of Ireland in 1991 and his European Diploma in Gastroenterology in 1995. He joined the Johns Hopkins faculty in 1999.

Dr. Goggins is a member of the Royal College of Physicians and the European Board of Gastroenterology. He sits on the editorial boards of Gut, Clinical Gastroenterology and Hepatology, and Cancer Biology and Therapy. more


  • Professor of Pathology
  • Professor of Medicine
  • Professor of Oncology

Departments / Divisions

Centers & Institutes



  • MD; University of Dublin Trinity College (1988)


  • St James's Hospital (1989)
  • Medicine; St James's Hospital (1991)


  • Johns Hopkins University School of Medicine (1998)
  • Internal Medicine; St James's Hospital (1995)

Board Certifications

  • Foreign Boards
  • Royal College of Physicians (Internal Medicine) (1991)

Research & Publications

Research Summary

Dr. Goggins’ current research is focused on discovering new markers of pancreatic adenocarcinoma using genetic, epigenetic and proteomic strategies, characterizing the epigenetic alterations in pancreatic cancers and normal tissues and identifying familial pancreatic cancer susceptibility genes through linkage, genome wide association and candidate gene approaches. Additional epigenetic studies are aimed at determining the functional and clinical significance of aberrant DNA methylation changes in pancreatic cancers.


In the Pancreatic Cancer Early Detection Laboratory, Dr. Goggins oversees research that focuses on gene expression patterns of pancreatic cancers using microarray technology. The lab is also studying DNA methylation patterns looking for genes that are methylated in pancreatic cancer but not in normal cells.

The lab has put together a profile of genes that are methylated in pancreatic cancer. Some pancreatic cancers methylate a lot of genes; most appear to methylate only a few genes. The lab is currently directing efforts to identify additional genes methylated in pancreatic cancer using novel techniques, and is studying the role of telomerase in pancreatic cancer and its potential as a marker for early detection.

Lab Website: Early Detection of Pancreatic Cancer Laboratory

Clinical Trials

The Cancer of the Pancreas Screening-5 CAPS5)Study

Selected Publications

Yu J, Blackford A, Dal Molin M, Wolfgang C, Goggins M. Time to progression of pancreatic ductal adenocarcinoma from low-to-high tumour stages. Gut 2015;epub Jan31. PMC4520782

Eshleman JR, Norris AL, Sadakari Y, Debeljak M, Borges M, Harrington C, Lin E, Brant A, Barkley T, Almario JA, Topazian M, Farrell J, Syngal S, Lee JH, Yu J, Hruban RH, Kanda M, Canto MI, Goggins M. KRAS and GNAS Mutations in Pancreatic Juice Collected From the Duodenum of Patients at High Risk for Neoplasia Undergoing Endoscopic Ultrasound. Clin Gastroenterol Hepatol 2015;13:963-9. PMC4404180.

Sadakari Y, Kanda M, Maitani K, Borges M, Canto MI, Goggins M. Mutant KRAS and GNAS DNA Concentrations in Secretin-Stimulated Pancreatic Fluid Collected from the Pancreatic Duct and the Duodenal Lumen. Clin Transl Gastroenterol 2014;in press. PMCID in process

Vincent A, Hong SM, Hu C, Omura N, Young A, Kim H, Yu J, Knight S, Ayars M, Griffith M, Van Seuningen I, Maitra A, Goggins M. Epigenetic silencing of EYA2 in pancreatic adenocarcinomas promotes tumor growth. Oncotarget 2014; 5:2575-2587. PMC4058028

Kim H, Saka B, Knight S, Borges M, Childs E, Klein AP, Wolfgang CL, Herman JM, Adsay V, Hruban RH, Goggins M. Having pancreatic cancer with tumoral loss of ATM and normal TP53 protein expression is associated with a poorer prognosis. Clin Cancer Res 2014;20: 1865-72 PMC3975663

Academic Affiliations & Courses

Graduate Program Affiliation



Activities & Honors


  • European Board of Gastroenterology
  • Royal College of Physicians of Ireland

Professional Activities

  • Ad hoc reviewer, Deafness Research Foundation, 2010
  • Ad hoc reviewer, Human Frontiers Science Program, 2010
  • Ad hoc reviewer, NIH Molecular, Cellular, and Developmental Neuroscience (MDCN) Special Emphasis Panel, 2013
  • Ad hoc reviewer, Communication Disorders Review Committee (CDRC) of the National Institute on Deafness and Communication Disorders (NIDCD), 2013
  • Ad hoc reviewer, Neurological Foundation New Zealand, 2013
  • Invited international reviewer, Deutsche Forschungs Gemeinschaft (DFG), 2014
  • NIH NIDCD, ad hoc reviewer, 2004
  • Publications Committee, Association for Research in Otolaryngology, 2014
  • Ad hoc reviewer, The Wellcome Trust, 1998

Videos & Media

Recent News Articles and Media Coverage

Genetic Testing May Hold Promise in Predicting Pancreatic Cancer, Inside Tract (Fall, 2019)

New Genetic Clues to Pancreatic Cancer, Clinical Connection (Fall, 2017)

Patient Ratings & Comments

The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

  • ...Loading ratings...
  • ... 
  • ... 
  • ... 
  • ... 
  • ... 


Is this you? Edit Profile
back to top button